CS

Challa Sailaja

Active Director Director DIN 08065552
DIN 08065552 First appointment Mar 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value •••• Premium profile

About Challa Sailaja

Data last updated:

Challa Sailaja is a Director at Hks Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Hks Pharmaceuticals Private Limited reported revenue of ₹6.2 Lakh (FY 2020).

DIN 08065552
Primary Designation Director
Industry Pharma
First Appointment 09 Mar 2018
Oldest Company Age 8 yrs
Largest company Hks Pharmaceuticals Private Limited · ₹6.2 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hks Pharmaceuticals Private Limited U24304TG2018PTC122801
Director09 Mar 20182018₹6.2 Lakh (FY 2020)Active

Board colleagues of Challa Sailaja

Directorship timeline

Open interactive timeline →
Hks Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Challa Sailaja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Challa Sailaja

Challa Sailaja currently holds 1 directorship: Hks Pharmaceuticals Private Limited (Director, since 09 Mar 2018, revenue ₹6.2 Lakh (FY 2020)).

Challa Sailaja was first appointed on 09 Mar 2018 as Director at Hks Pharmaceuticals Private Limited.

The current boards of Challa Sailaja's companies include Nallareddy Harshavardhan Reddy (Hks Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available